Drosophila melanogaster and plants as well as in human cell lines ( ). 7 -13 When mature miRNAs differ by a few bases, a letter is added as a suffix, reflecting the difference:
., miR-181a and miR-181b: e.g miR-181a: aacauuca gcugucggug gu ac a miR-181b: aacauuca gcugucggug gu uu g
When both strands of a pre-miRNA are processed as mature miRNAs, an indication is given to specify which arm of the hairpin structure of the pre-miRNA generates one or the other of the two miRNAs. Several nomenclatures can be used:
miR-X and miR-X : miR-X is the less abundant of the two mature miRNAs in the cells.
* * miR-X-5p and miR-X-3p: 5p and 3p stand for the 5 and 3 arms of the stem-loop structure of the pre-miRNA, respectively. This ′ ′ nomenclature is mainly used when the respective abundance of the two miRNAs is still unknown ( ). 15
miR-X-s (5 arm) and miR-X-as (3 arm).
′ ′
Moreover, a mature miRNA can result from the transcription and maturation of transcripts from separate genomic loci. A numeral suffix is added to the names of all the multiloci miRNAs, , miR-181a-1 and miR-181a-2 (miR-181a-1 originates from a locus on e.g. chromosome 1 and miR-181a-2 from a locus on chromosome 9). Nevertheless, some miRNAs, such as hsa-let-7 and cel-lin-4, do not follow the above-described nomenclature.
Interfering RNAs: similarities and differences RNA interference (RNAi) is mainly responsible for the post-transcriptional regulation of gene expression (mRNA cleavage or decay, translation repression or activation) but is also involved in transcriptional regulation as described by various studies ( ). 16 -19 Mainly two classes of small RNAs interfere in the RNA interference process: miRNAs and siRNAs (short interfering RNA). These
RNAs share similarities such as their short size (about 22 nucleotides), their maturation by the ribonuclease III Dicer, and their implication in the RISC complex for post-transcriptional repression.
Nevertheless, there are a number of important differences, such as the following: miRNAs are exclusively endogenously produced. They come from intrinsic genes of the organism they interfere in, whereas siRNAs may originate from viruses, transposable elements, perfectly paired endogenous double-stranded RNA resulting from an antisense transcription of various loci ( ), or transfected exogenous and double-stranded RNAs. 20 miRNAs play a role in the regulation of genes that do not generate them, whereas siRNAs mainly regulate the genes that produce them. This point is critical in order to secure host cell defense against parasite RNAs such as viruses or transposons.
In mammals, miRNAs have a varying degree of complementarity with their target, whereas siRNA always have a perfect complementarity with their targets. When the complementarity is perfect, the target mRNA is degraded in the presence of the Ago2 protein, which is the sole protein of the four Argonaute family proteins responsible for endonucleolytic cleavage. In plants, the difference between miRNAs and siRNAs is very small because the pairing between miRNA and mRNA is often perfect ( ). 21
In addition to miRNAs and siRNAs, there are other small RNAs that contribute to maintaining the genome integrity: the piRNAs (piwi-interacting RNAs). They are longer (26 31 nucleotides), abundant in germinal cells but can also be found in somatic tissues ( several studies showed the presence of piRNAs in mammals ( ). Contrary to siRNA and miRNA, it seems that they come from long 25 -28 single-stranded RNA precursors and their biogenesis does not include the RNAse III Dicer. Once matured, piRNAs associate themselves with PIWI proteins, a subfamily of Argonaute proteins, principally to target transposons and preserve genome integrity ( ). 22
miRNA biogenesis
Localization and structure of miRNA coding genes
These genes are widespread on all chromosomes except for chromosome Y and approximately 50 of the described miRNAs are % located in clusters. When these clusterized miRNAs are under the control of a single promoter, they are dubbed polycistronic miRNAs.
miRNA coding genes can be independent gene units and miRNAs are then called intergenic; they can also be gene units coding for pre-mRNA that either code for proteins or do not code for them. In this case, miRNAs can be intronic or exonic ( ) ( ). Figure 4 29 -31 Transcription of primary miRNA transcript 3 28 Most of the miRNA coding genes are transcribed by the RNA polymerase II, producing long primary transcripts (pri-miRNAs). These pri-miRNAs have a typical structure composed of a stem (about 33 nucleotides), a loop connecting the two strands of the stem, and single-stranded flanking sequences ( ). Like mRNAs, these sequences contain a 7-methyl-guanosine (m7G) cap at their 5 end and Figure 5 ′ a 3 polyA tail ( , ) . With the transcription performed by the RNA polymerase II, the regulation of this mechanism could be similar to TSS sequences of miRNAs in human using high-throughput genomic analyses such as chromatin immunoprecipitation ( , ). 37 38
Maturation of pri-miRNAs into miRNAs

Formation of the pre-miRNA in the nucleus
In human, primary transcripts are processed in the nucleus by a protein complex called microprocessor that is composed of the ribonuclease Drosha associated with its cofactor DGCR8 (DiGeorge syndrome Critical Region gene 8) ( ). The Drosha complex also 39
contains several other factors such as EWSR1, FUS, numerous heterogeneous nuclear ribonucleoproteins (hnRNPs), p68 (DDX5) and p72
(DDX17) DEAD-box helicases. The roles of these accessory components in miRNA maturation is largely unknown, some hnRNPs and p68/p72 may promote the fidelity and activity of the Drosha processing ( , ). DGCR8, which interacts with double-stranded RNA, is 40 41 required to allow the binding of the Drosha/DGCR8 complex to the pri-miRNA at the junction between the flanking sequences and the stem-loop. Once the complex is bound to the pri-miRNA, DGCR8 specifies the Drosha cleavage distance (~11 bp) away from the junction between the flanking sequences and the stem-loop. The Drosha enzyme is a class 2 ribonuclease III, , it contains two RNAse III i.e. domains and one binding domain for double-stranded RNA. This structure allows an asymmetric cleavage of the double-stranded RNA and the release of a shortened pri-miRNA stem-loop ( ). This shortened stem-loop is called pre-miRNA and contains two unpaired 42 nucleotides at the 3 end and a phosphate group at the 5 end ( ) ( ).
′ ′
Figure 5
Another pre-miRNA biogenesis pathway is the mirtron pathway, which is connected to the mRNA splicing mechanism. After splicing and lariat release, the intron structures itself in a stem-loop to generate a pre-miRNA. In this case, the mechanism of mirtron maturation bypasses cleavage by the pre-miRNA generating enzyme Drosha. The pre-miRNA 5 and 3 ends correspond to the donor splicing site ′ ′ (GU) and the acceptor splicing site (AG), respectively. This mirtron pathway, first described in the invertebrates et
, was then evidenced in mammals (such as miR-877 and miR-1224) ( ). The main difference between the invertebrate elegans 44 45 46 and mammal mirtron pathways seems to rely on the fact that the mature miRNA is usually located on the 3 strand of the stem-loop in ′ invertebrates while it is located on the 5 strand in mammals ( ).
′
Figure 6
Pre-miRNAs export from the nucleus to the cytoplasm
The export of RNAs (messenger, ribosomal, and transfer RNAs) is made possible by the action of receptors of the karyopherin family, such as CRM1 and exportin-t (Exp-t). Nevertheless, nuclear-export of pre-miRNAs mostly relies on another receptor called exportin-5
(Exp-5) ( , ). This receptor, discovered in 2002, belongs to the karyopherin family. Like all the other receptors of this family, it 47 48 β binds directly and specifically to the RAN-GTP protein (RAS-related nuclear protein with bound GTP) in the nucleus and then binds to nucleoporins to allow the pre-miRNA transfer from the nucleus to the cytoplasm ( ). Exp-5 specifically interacts with double-stranded 49
RNAs longer than 14 bp that contain a protruding 3 end ( ), hence its binding specificity for pre-miRNAs ( ). Once the
pre-miRNA/Exp-5/RAN-GTP complex is assembled and is bound to nucleoporins, it goes through the nuclear pores. Then the RAN-GAP enzyme (RAN-GTPase activating protein), located on the cytoplasmic side of the pores, activates the hydrolysis of the RAN-bound GTP into RAN-bound GDP ( ), leading to the release of the pre-miRNA in the cytoplasm ( ). 52 Figure 7 Mature miRNA production in the cytoplasm
In the cytoplasm, pre-miRNAs become the substrates of the ribonuclease III Dicer, which completes their processing. Previously described for siRNA processing ( ), Dicer was found to be involved in the final cleavage of pre-miRNAs into 21-nucleotide miRNAs in 53 ( , ). Dicer is a class 3 type III ribonuclease composed of two RNAse III domains, one double-stranded RNA (dsRNA) C. elegans 54 55 binding domain, one PAZ signature (Piwi/Argonaute/Zwille), and a helicase domain. The PAZ domain allows Dicer to recognize the single-stranded 3 overhangs of the pre-miRNA ( , ). In addition, the dsRNA binding domain allows the recognition of the stem by Dicer ( , ) and the cleavage by the RNAse III domains of the dsRNA about 21 nt away from the PAZ-bound end. This cleavage 58 59 generates another single-stranded 3 overhang ( ).
′
Figure 8
Gene expression regulation by miRNAs
miRISC (miRNA-induced silencing complex) formation
During the maturation step catalyzed by Dicer, two other proteins, TRBP (TAR (HIV-1) RNA binding protein or TARBP2) and Ago2
(Argonaute 2), were found to be involved in the formation of the RISC loading complex (RLC) with Dicer ( carried out with recombinant proteins revealed that the association of only three proteins Dicer, TRBP, and Ago2 makes an in vitro --equistoichiometric complex that is able to process the pre-miRNA and to select one of the two strands to form the miRISC. The dimeric TRBP ( ) first dissociates into monomers to form the RLC. In drosophila, the assembly of the Dicer/TRBP/Ago complex requires ATP ( 64 ) , whereas in human, assembly of the complex can be either ATP-independent ( ) or ATP-dependent ( ). 65 61 -63 66
The RNA duplex obtained after maturation contains 2-nt 3 overhang ends, resulting from the action of the two type III RNases, ′ Drosha and Dicer. In some rare cases, the two duplex strands can accumulate in the cell ( , ) with both strands acting as mature strands 6 67 to guide the miRISCs to the mRNA targets ( 
77
RLC allows the loading of the mature miRNA into the miRISC after the dissociation of the two strands. Among the three in fine proteins that take part in the RLC (Dicer, TRBP, and Ago), only the Ago component is required for RISC activity in the miRISC ( Figure 9 ). Argonaute proteins are composed of two main regions: one containing the N-terminal and the PAZ domains, the other one containing the Mid and PIWI domains ( ). Although the functions of these domains are poorly defined, it seems that the three domains PAZ, Mid, and 78 -PIWI play an important role in the RNA interference phenomenon as they are required for the interaction with the miRNA. Indeed, the -PAZ domain, which is similar to the Dicer domain, binds to RNA duplexes containing two unpaired nucleotides on the 3 end and Interaction between miRNAs and mRNA targets
Mechanisms of interaction
The main interaction between miRNAs and target messenger RNAs occurs at the level of the mRNA 3 UTR and generates duplexes.
′
In plants, most miRNAs show a perfect complementarity with their mRNA targets and perfect duplex formation is associated with the degradation of the targets by endonucleolytic cleavage ( , ). On the contrary, in metazoans, a perfect complementarity between 86 87 miRNAs and their mRNA targets is not always the rule.
Several specific features of duplex formation have been described which were used to define algorithms to predict miRNA targets. In
2003, Lewis
reported that the hybridization between miRNA and its mRNA target has to be perfectly complementary between et al. nucleotides 2 and 7 from the 5 end of the miRNA; this region was called the seed region ( ). Any mismatch in this region and in ′ 88 particular any G:U type mismatch would more or less severely reduce the miRNA efficiency to interact with a given mRNA target, depending on the size of the seed region ( , ). For example, with a 6-nt seed region, a G:U type mismatch leads to a complete loss of 89 90 the miRNA activity. In addition, the presence of an A residue in position 1 and/or an A/U residue in position 9 from the 5 end of the ′ miRNA ( , on both sides of the seed region) may improve the interaction between miRNA and the targeted mRNA ( ).
i.e. 91
Another feature is the presence of a mismatched bulge in the middle region of the miRNA mRNA duplex, which prohibits the -endonucleolytic cleavage catalyzed by Ago2 ( ). In addition, a sequence complementarity on the 3 end of the miRNA stabilizes the 92 ′ miRNA mRNA duplex, especially when it occurs between nucleotides 13 and 16 from the 5 end of the miRNA ( ).
-′
93
Finally, other factors can improve the miRNA efficiency such as AU-repeat mRNA sequences close to the miRNA binding site, or the proximity of the miRNA site to the stop codon or to the polyA tail of the target, especially for mRNA with long 3 UTR (>1300 nt).
′
However, for a distance between the miRNA site and the stop codon shorter than 15 nucleotides a severe drop in miRNA efficiency is expected. Proximity to the stop codon and to the polyA tail of the miRNA site increases the accessibility of the miRISC. Moreover, the 5 28 binding of several different miRNAs to the 3 UTR promotes the cooperative repressing phenomenon ( ). All these structural features are ′ 94 summarized in . Figure 10 Besides the above-mentioned canonical mechanisms of miRNA gene regulation through 3 UTR interactions, other non-canonical 
Categories of target sites
Several categories of target sites have been described according to their structural features ( , ). There are two main categories, 91 97 which can be called canonical or marginal sites, and more rarely, atypical sites ( ). Canonical sites are characterized by strong Figure 11 pairing in the seed region and contain three types of sites (8mer, 7mer-m8, and 7mer-A1). The 8mer sites have an interaction on 8 nucleotides including the 6 seed region nucleotides (nucleotides 2 7), and nucleotides in positions 1 and 8. The 7mer-m8 and 7mer-A1 Table 1 TargetScanS is considered the simplified and improved version of TargetScan. Indeed, in this version, the necessary pairing is only 6 nucleotides in the seed region and the target site number on a single mRNA is not required in this version. The three biocomputational tools, TargetScanS, PicTar, and EIMMo have many common putative target sites because the engines look for sites with strong base-pairing in the seed region. However, there is no perfect overlapping between the results obtained with these three engines that use different UTR databases and/or miRNA sequence files ( ). Moreover, these algorithms have some intrinsic differences in the criteria 105 for mRNA target prediction. For example, TargetScanS requires that the mRNA target site ends by an A residue located in complementarity to the first miRNA 5 nucleotide, whereas the two other algorithms allow any Watson-Crick base pairing in this position (
The reliability of these algorithms is sometimes questionable (see for example ( )). In order to reduce false-positive or 106 false-negative targets of miRNAs, a useful tool, TargetCombo ( ), has been http://www.diana.pcbi.upenn.edu/cgi-bin/TargetCombo.cgi developed to combine many data sets. In particular it is possible to query files that combine all the targets predicted by at least one of the databases, Diana-microT, TargetScanS, miRanda and PicTar, or the targets all predicted by TargetScanS, miRanda and PicTar, or finally the results obtained with TarBase ( ). The biocomputational tool TarBase ( ) compiles all the 105 http://diana.cslab.ece.ntua.gr/tarbase experimentally validated targets ( , ). 107 108
Molecular mechanisms of translation regulation of mRNA targets by miRNAs mRNA maturation, stability, and translation: basic features
After transcription, mRNAs are processed by addition of a cap m7G at the 5 end, a polyA extension at the 3 end, and by appropriate ′ ′ exon splicing. Cap and polyA tail strengthen mRNA stability since they interact with specific protein complexes that prevent exonuclease activity due to steric hindrance. mRNA stability is also regulated by the AU-rich elements binding proteins (ARE-BP), which bind to AU-rich domains located in the 3 UTR of mRNAs.
′
In the cytoplasm, mRNA translation requires three major steps: initiation, elongation, and termination ( , ). The initiation 109 110 occurs at the level of the cap, with first association of the 40S ribosomal subunit, methionine initiator tRNA, protein factors to aggregate in a 43S preinitiation complex, and involvement of the eIF4F complex. The 43S complex then shifts to the initiation codon AUG and partially dissociates, while a 80S is assembled by binding the 60S ribosomal subunit prior to translation.
Alternatively, translation initiation may rely on the recruitment of ribosomes by an internal ribosome entry site (IRES) and does not need the loading of the initiation protein complex at the mRNA cap structure ( ). The IRES sequences are characterized by stem-loop 111 secondary structures in the mRNA 5 UTR that contain an initiation codon at their 3 ends. The 40S ribosomal subunit binds directly to the ′ ′ initiation codon and initiates translation. After translation initiation, the ribosome moves codon by codon and recruits amino acid-loaded tRNAs. At the level of a stop codon, the action of termination factors promotes ribosome dissociation and translation stops. Translation initiation is a key step for translation regulation ( ), and it is frequently repressed by miRNAs.
Translation initiation repression by miRNAs
Several studies carried out on cultured cells demonstrated that the functional m7G cap is required for translation inhibition by miRNAs to take place. Indeed, miRNA inhibition of translation is impeded when mRNAs have a nonfunctional cap structure or when they are translated from IRES ( , ). Some mRNAs have a bicistronic feature, with one cistron translated in a cap-dependent way and 112 113
another one translated from IRES. In this case, only the translation of the first cistron is repressed by miRNA ( ). The importance of the 113 m7G cap structure in the regulation of translation initiation is also illustrated by the fact that the central domain sequences of Ago proteins share some similarities with the central domain of the eIF4E factor, the cap-associated factor essential for translation initiation. In the Ago2 central domain, there are two phenylalanine residues that have proved to be necessary for binding Ago2 at the cap. Consequently, these proteins may inhibit initiation translation by competition with cap-associated factors such as eIF4E for binding to the cap (112 -114 ). In addition, translation initiation repression mediated by miRNA may rely on interaction between the miRISC complex and the eIF6 factor. This factor prevents the association between the 60S ribosomal subunit and the 40S ribosomal subunit and blocks translation initiation (
). The different mechanisms of the regulation of mRNA target expression by miRNAs are shown in . 115 Figure 12
Repression of the postinitiation step of translation by miRNAs
Studies conducted on highlighted that lin-14 and lin-28 mRNAs, the targets of the lin-4 miRNA, are associated with C. elegans polysomes, while they are poorly translated into proteins ( , ). mRNA association with polysomes is usually a sign of strong 116 117 translation activity. A low level of lin-14 and lin-28 mRNA translation could then be taken as an indication that miRNAs can play a role in translation inhibition at a postinitiation step. Similar situations were also observed in mammals. Indeed, Petersen ( ) reported that et al. 118 IRES-dependent translation of mRNA (a process that does not rely on a cap-dependent initiation step) can also be repressed by miRNAs.
They found that miRNAs and their mRNA targets are present in translation-active polysomes and, in the presence of puromycin, which aborts the translation elongation step, miRNAs and mRNAs are finally found in the translation-inactive polysomes. It was then concluded that the postinitiation repression mechanism is due to a premature release of ribosomes (called drop off) during the elongation step ( ). 118
Postinitiation repression was also observed in HeLa cells in Kras mRNA, a let-7 target ( ). Let-7 leads to inhibition of Kras expression 119 and both the miRNA and its mRNA target were found associated with translation-active polysomes. However, the authors suggested that in this case, the miRNA-mediated postinitiation repression mechanism stems from a decrease in the speed of translational elongation.
Finally, Nottrot ( ) also found miRNAs and mRNAs associated in polysomes, and concluded that translation repression by et al. 120
miRNA could be the result of a degradation of the newly synthesized polypeptide.
Regulation by degradation of the mRNA targets
Several studies reported that miRNAs repress protein expression with limited effects on the levels of the target mRNAs. Nevertheless, other studies reported a miRNA-mediated decrease in stability of the mRNAs. For example, in let-7 decreases lin-41 mRNA C. elegans stability and lin-4 reduces the stability of both lin-14 and lin-28 mRNAs ( ). In human, lin-28 mRNA stability is lowered by miR-125a 121 and miR-125b ( ). Moreover, in mammals miRNAs were reported to reduce protein output mainly by destabilization of target mRNAs ( 122 ) . Accelerated deadenylation of the polyA-tailed target mRNA was reported to be a key step in miRNA-mediated mRNA decay ( ). 123 124
In eucaryotes, deadenylation is first initiated by the PARN2/PARN3 complex and then requires a protein complex composed of NOT and two deadenylases, CAF1 and CCR4 ( ). Once deadenylated, mRNAs can be degraded by exonucleases from their two ends. The 5 125 ′ -to-3 end degradation is performed by the Xrn1 exonuclease after cap removal. In human, this step involves a complex made of DCP2 and ′ several cofactors such as DCP1, EDC3, Ge-1, and RCK/p54 ( ). All these proteins involved in the 5 -to-3 end degradation are located 126 These p-body cytoplasmic granules, also important in RNA interference phenomena, contain the GW182 protein, a 182-kDa protein containing glycine-tryptophane (GW) repeated elements ( ). This protein is able to bind to Argonaute proteins, present in p-bodies 130 associated with miRNAs and mRNA targets ( ). Stress granules are another kind of cytoplasmic granule produced by eucaryote cells 131 subjected to stress, such as oxidative stress, thermic shock, or UV irradiation ( ). Using immunofluorescent techniques, stress granules 132 and p-bodies were proved to be two independent and distinct structures ( , ). These cytoplasmic granules are a storage place for 133 134 nontranslated mRNAs.
Translation activation by miRNAs
In most of cases, miRNAs play a role in negative regulation of gene expression by mRNA target translation repression or by mRNA degradation. Nevertheless, in a few cases positive regulation by translation activation has been observed and especially in conditions of cellular stress. ARE sequences (AU-rich elements) located in the mRNA 3 UTR are critical elements for translation activation. It was ′ shown that Ago2 and FXR1 bind to ARE sequences in order to activate the translation of the TNF factor in cultured cells under serum α privation and to stop the cell cycle ( ). miR-369 which has a seed region complementary to two target sites of the ARE sequence of the 135 7 28 TNF coding mRNA was shown to recruit Ago2 and FXR1 and to activate TNF translation under serum privation conditions. It has been α α concluded that miRNAs may play a role of translation repressors in proliferating cells and a role of translation activators in cells blocked at the G0/G1 stage. Consequently, Ago2 may be involved in either activation or repression of mRNA translation ( ). 135
Interestingly, mRNA translation activation by miRNA was also reported to proceed through an indirect action of miRNA by Eiring et ( ). In the specific case of the chronic myelogenous leukemia, miR-328 was found acting as a decoy by binding to heterogeneous al. 136 ribonucleoprotein hnRNP E2 in a miRNA s seed sequence independent way and this relieves the hnRNP E2 dependent translational ' repression of the CEBPA mRNA involved in myeloid cell differentiation.
miRNAs play an important role in translation regulation since it is assumed that up to 60 of the protein coding genes can be under % the control of miRNAs ( ). They are strongly involved in many cell processes such as development, differentiation, proliferation, and 98 apoptosis ( , ), all processes that are often deregulated in tumors. miRNA are believed to provide major contributions in 21 137 -140 tumorigenesis and description of these pathological roles at a molecular level are now increasingly documented. and miR-222 appeared to be consistently overexpressed in many tumor tissues (brain, thyroid, gastrointestinal tract, liver, lung, and breast), whereas others such as miR-143, miR-145, and the let-7/miR-98 cluster were found to be underexpressed in tumor tissues.
However, the expression of several miRNAs is not always modified identically in all types of cancer. For example, the mir-17/92 cluster has been reported to be overexpressed in seven tumor types and underexpressed in three others. miRNAs are also interesting diagnostic biomarkers distinguishing different subtypes of tumors from the same tissue, such as in gliomas ( ), thyroid cancer ( ) or renal cell carcinoma ( ). 144 145 146 Deregulation of miRNA expression by defects in the biogenesis mechanism Altered expression of the proteins involved in the miRNA biogenesis and maturation machinery has been observed in several cancers.
For example, deregulation of Drosha expression is associated with ovarian cancer ( ), skin epithelium cancer ( ), and esophagus 147 148 tumors ( ). A high Drosha expression level is associated with a poor survival prognosis. Interestingly, when esophagus tumor cell lines 149 were transfected by siRNAs designed to target the Drosha coding mRNA, a significant decrease in the cell proliferation was noted ( ). 149
Inactivating mutations in XPO5, coding for Exportin 5, have been discovered in several cancer cell lines with microsatellite instability ( ). These mutations lead to trapping pre-miRNAs in the nucleus, thus preventing miRNA processing. 150
Dicer was also found to be overexpressed in lung carcinoma and prostate adenocarcinoma ( , ) and underexpressed in 151 152 high-grade ovarian carcinoma, small-cell lung tumors with poor prognosis, and invasive lung adenocarcinoma ( , , ). In 147 152 153 addition, frameshift mutations in the TRBP2 genes were found to diminish the TRBP protein expression. This causes destabilization of the DICER complex and a defect in the processing of miRNAs ( ). 154
Expression and activity of some major components of the miRNA processing pathway such as Drosha/DGCR8, Dicer/TRBP2 or Argonautes may be regulated by the transcription factors p53, p63, and p73 ( ). The promoters of the genes coding for Drosha, 155 DGCR8, Dicer and TRBP contain p53-RE sequences indicating that they could be direct transcriptional targets of p53 and preferentially of p63/p73. Moreover, direct interactions between WW domains in p63 and p73 and PY domains in DGCR8 protein may influence miRNA
processing components, at both the transcriptional and post-transcriptional levels.
Deregulation of miRNA expression by chromosomal rearrangements
Two studies highlighted that miRNA genes are located in chromosomal regions that are frequently altered in cancers ( , ). 156 157 Alterations of the copy number for 37 , 73 , and 86 of 283 miRNA coding genes were pinpointed in ovarian cancer, breast cancer, and % % % melanoma, respectively. Nearly 40 miRNA coding genes are altered in common in these three types of tumor ( ). Modifications of the 157 expression of miRNA coding genes may result from chromosomal translocation, leading, for example, to overexpression of the gene coding for miR-125b, due to translocation t(2;11) in some types of leukemia ( ). They may also be linked to amplification or deletion 158 of genomic regions. This is exemplified in the 17q23 region, which was found to be amplified in neuroblastoma (
). This region hosts 159 the gene coding for miR-21, which is usually upregulated in tumors. Another example is the presence of a deletion in the 13q14 region in several cases of B-cell chronic lymphoid leukemia. Genes coding for miR-15a and miR-16-1, underexpressed in 68 of these types of ). In another type of lymphocytic leukemia, MLL-AF4 acute lymphocytic leukemia, miR-128b has been found to be underexpressed 167 in tumor samples, due to a mutation in the primary transcript located 13 bp from the 3 end of mature miR-128b ( ). This mutation also
contributes to glucocorticoid resistance of tumor cells.
Modifications of miRNA expression due to transcriptional regulation
Transcription of miRNA encoding genes by RNA polymerase II can be regulated by several transcriptional factors. In the flanking regions of miRNA-coding genes in and in humans the presence of patterns involved in transcriptional regulation has been C. elegans studied ( ). A number of transcriptional factors such as p53, E2F, and Myc have been reported to play a role in this regulation. 169 p53, known to be a tumor suppressor, has been highlighted as a transcriptional regulator of several miRNAs ( ). It acts as a 170 transcription activator of the miR-34a gene, as it can bind to the promoter region of this gene ( ). It may also impair the 171 -173 expression of several miRNAs by inhibition of the transcription factor E2F1 ( ). Activation by transcription factors belonging to the 174 E2F family has been reported to increase the expression of some miRNAs ( ). Another transcription factor, Myc, which has oncogenic 175 properties, has been described as an expression modulator for a number of miRNAs. Indeed, by binding to promoter regions, Myc has been shown to be an expression activator of the miR-17/92 cluster, for example ( ), but also an expression repressor for many miRNAs 176 involved in proliferation processes ( ). 177
Transcription regulation, which can account for a modulation of miRNA expression levels, can also result from epigenetic modifications at the promoter regions of specific miRNA coding genes. One important epigenetic modification is DNA methylation, which is a reversible phenomenon and involves only cytosines belonging to CpG dinucleotide motifs. CpG-rich genomic domains, called CpG islands, can be located in several promoter regions. DNA methylation of CpG islands in promoters is a phenomenon that controls the expression level of downstream genes, as this modifies the chromatin structure and consequently the binding of transcription factors; in addition it favors MBD (methyl-DNA binding) protein fixation ( ). 178
The role of DNA methylation in repression of miRNA expression was confirmed by using DNA demethylation drugs on cultured tumor cells that promote miRNA overexpression ( ). Several miRNAs have been studied more specifically, such as miR-124 ( 179 - 181 181 ) and miR-34a ( ), for which the lower expression in cell lines or in tumor tissues is due to a hypermethylation of CpG islands, and 182 miR-128 (
) and let-7a-3 ( ), which are overexpressed due to a hypomethylation of CpG islands. 183 184 9 28 Modifications of the interactions between miRNAs and their mRNA targets
Deregulation by chromosomal modification
As mentioned above, several genomic alterations, such as chromosomal rearrangements or point mutations, may rationalize the differences observed in miRNA expression between tumor and normal tissues. These alterations are important events in the tumor genesis process, as they prevent proper regulation of normal cellular processes by miRNAs. In addition, and similarly, genomic alterations can also affect the 3 UTR sequences of mRNA targets and lead to gene regulation modifications by impairment of the miRNA/mRNA target
One study demonstrated that a 4-nt TTCA insertion in the 3 UTR of the IL-1 alpha mRNA significantly disrupts a binding site for ′ miR-122 and miR-378 and has a substantial influence on IL-1 alpha expression regulation ( ). Studies conducted on mantle cell 185 lymphoma have shown high expression of CCND1 in these tumors due to deletions and mutations in the CCND1 mRNA 3 UTR ( ).
′
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These sequence modifications impair the interaction between CCND1 mRNA and miR-16, increasing the expression of the CCND1 protein ( ). Genomic translocation can delete the normal 3 UTR part of the mRNA coding for HMGA2, making let-7 unable to bind to 187 ′ this region and to restrain HMGA2 expression (
). This protein has been shown to be involved in the tumorigenesis of many malignant 188 tumors such as lung cancer ( ) and pancreas cancer ( ). 189 -191 192 In the case of ABCG2 (a ubiquitous ATP-binding cassette (ABC) transporter, playing a role in absorption, distribution, and elimination of drugs), a shortening of the 3 UTR mRNA has been detected in drug-resistant colon cancer cell lines, leading to a loss of a . Indeed, overexpression of this cluster seems to accelerate tumor development of B-cell 201 202 lymphoma in mice expressing c-myc. miR-155 is also described as an oncogenic miRNA, as it is overexpressed in B-cell lymphoma ( , 142 ). Some miRNAs, such as miR-21, are also considered as oncogenes when they can repress the expression of tumor suppressor 203 -206 proteins. miR-21 is overexpressed in many tumor types and targets the mRNAs of tumor suppressors PDCD4 and TPM1 ( , ). 143 207 -210 On the contrary, other miRNAs have been described as tumor suppressors: let-7 ( , , ) as well as miR-15a and miR-16-1 ( 156 189 211 -216 , ). miR-34a is also considered a tumor suppressor repressing several oncogenic genes, such as c-Met in brain tumors ( ) 160 217 -220 221 and uveal melanoma ( ) or Bcl-2 in neuroblastoma ( ). 222 223
For a more comprehensive list of oncogenic or tumor suppressor miRNAs, the reader is referred to the miR 2 Disease database ( ( )). www.mir2disease.org 224 miRNAs involved in tumor development can control many key signalization pathways such as apoptosis, cellular proliferation, and angiogenesis.
Apoptosis and cellular proliferation processes
The apoptosis process can be activated two pathways, the intrinsic and the extrinsic pathways ( ). In the intrinsic one, via Figure 13 several pro-apoptotic and anti-apoptotic members of the Bcl-2 family are involved and their actions are antagonized to regulate mitochondrial membrane permeability. The anti-apoptotic proteins Bcl-2 and Bcl-xL are often overexpressed in tumors ( ) and 225 -227 prevent mitochondrial permeabilization by inhibition of the cytosolic pro-apoptotic Bax and Bak ( ). After a cellular stress, expression 228 of pro-apoptotic members of the Bcl-2 family such as Puma and Noxa is enhanced by p53-dependent transcriptional activation.
Subsequent activation of Bax and Bak proteins then allow their migration to the mitochondrial membrane where they concur to increase the permeability of the mitochondrial membrane. This permeabilization is associated with a release of cytochrome into the cytoplasm ( c ), which binds to the APAF-1 protein (apoptotic protease-activating factor-1) and to two procaspases-9 to form the apoptosome. Then 229 this protein complex promotes the activation of caspase-9, an apoptosis-initiating caspase ( ). Activated caspase-9 cleaves 230 procaspase-3, -6, or -7. In normal conditions, activation of these caspases is inhibited by proteins called IAPs (inhibitor of apoptosis protein). IAPs are inhibited by Smac/DIABLO proteins that are released into the cytoplasm after membrane permeabilization of mitochondria ( , ). 231 232 As for the extrinsic apoptotic pathway, it starts outside of the cell with an activation of the pro-apoptotic receptors at the surface of the ). miR-17/92 was found to be overexpressed in many cancers such as B-cell lymphoma. The 237 miR-106b/25 cluster was found to be overexpressed in many gastric and prostate cancers. Some miRNAs, most particularly miR-106b, are assumed to target Bim but also p21, which is involved in cell cycle control, and E2F1 ( , ). miR-34a is also an important regulator 238 239 of the initiation of the apoptosis pathway, as this miRNA lowers the expression of the deacetylase SIRT1. This leads to the acetylation of p53, the increase in its transcriptional activity, and the induction of the pro-apoptotic protein Puma ( ). A recent study showed that 240
Puma is the target of two miRNAs, miR-221/222, in glioblastoma cells ( ). These two miRNAs also play an important role in cellular 241 proliferation by regulation of p27 expression ( ). Kip1 
242
The second part of the intrinsic pathway, with apoptosome formation and activation of caspases, is also regulated by miRNAs. For example, miR-1 and miR-133 are co-transcribed from the same polycistron, but they have antagonistic roles in apoptosis, as miR-1 has a pro-apoptotic effect, whereas miR-133 is an anti-apoptotic factor. In fact, miR-1 targets the anti-apoptotic proteins HSP60 and HSP70, two proteins that prevent apoptosome formation, while miR-133 represses caspase-9 expression ( ). miR-21 also plays an anti-apoptotic 243 role initially observed in glioblastoma cells ( ), since this miRNA regulates the expression of APAF-1, caspase-3, and PDCD4 ( ). 244 245 In addition, PDCD4 also regulates caspase-3 activity ( ). 246
The extrinsic pathway can be the target of miR-21 and miR-182, which control the expression of FAS-L ( ) and protein FADD ( 247 ), respectively. 248
Angiogenesis process
Growth of new blood vessels from preexisting vessels, a process called angiogenesis, is a key step in tumor progression ( , ).
250
The control of this process by miRNAs has been evidenced to occur after the experimental knockdown of Dicer, by the transfection of specific siRNAs in endothelial cells. Indeed, the reduction of the expression of Dicer led to a decrease in angiogenesis, by a reduction of ). miR-126, the only endothelial cell-specific miRNA, was studied in a mouse model in which a drop 253 in vivo in the expression of this miRNA was correlated with a decrease in angiogenesis and vascular integrity ( ). The same conclusion was 254 The miRNAs miR-15b and miR-16 target the VEGF-coding mRNA and thus have anti-angiogenic properties ( ). 263
Exosomal miRNAs: new potential tumor biomarkers
Quantitative analyses of miRNA expression in tumor tissues revealed that miRNAs can be regarded as appropriate biomarkers that can help discriminate tumor types. miRNA profiling for tumor typing appears to be an attractive approach for diagnosis as a complement to pathology methods (
). This can be performed directly on tumor tissue specimens, but other less invasive approaches are currently 144 under investigation. These approaches are based on the fact that miRNAs can be found in detectable amounts in small membrane vesicles It should be noted that exosomes may also have considerable implications in cancer development, given that these vesicles have been reported to be involved in an intercellular transfer of the mRNAs and miRNAs they contain between glioma cells ( ), or from tumor 282 cells into normal cells in the tissues ( , ). Also, exosomes derived from cancer stem cells, which seem to be responsible for the 264 283 increase in tumor growth, invasion, or vascularization, could establish a premetastatic niche away from the tumor tissue ( ). 284
miRNAs in cancer therapy
With the discovery of the role of miRNAs in controlling the expression of many proteins, and moreover that they behave as oncogenic or tumor suppressor components, it soon became clear that miRNAs can be involved or may be used in new therapeutic approaches. It goes without saying that taking advantage of miRNAs in new antitumor developments requires that a number of hurdles be overcome (285 ) .
Briefly, miRNAs intrinsically have a number of attractive features for therapy. Their mechanism of action guides the therapeutic process. In comparison to small inhibitory molecules that reduce the activity of targeted enzymes but leave the amount of cellular enzyme intact, miRNAs can be used to reduce the cellular concentration of targeted proteins. miRNAs are natural cellular components and they include an intrinsic signature that may ensure specificity to target. These may have important consequences in the control of side effects.
Nevertheless, accurate miRNA-target recognition is not perfectly managed (see above) and off-target effects are still dreaded. On the other hand, one single miRNA can target several oncogenic proteins and the opportunity to simultaneously repress several oncogenes with only a single miRNA appears very attractive in the search to improve anticancer therapy, while limiting possible side effects. An example of this multitarget therapy can be found with miR-34a, which represses c-Met, CDK4 (cyclin-dependent kinase 4), and Bcl-2 (B-cell lymphoma 2), all involved in separate oncogenic pathways ( ). 286 12 28 miRNA-based therapies can be tentatively classified according to two different criteria: the antitumoral effects that are strategically expected and the mode of action triggered. First and most specifically, several antitumoral effects can be putatively promoted using miRNA-based strategies ( ). Indeed, given the numerous roles played by miRNAs in the tumor physiopathology mentioned above, 287 ovarian cancer, several miRNAs are involved in drug resistance, such as miR-30c, miR-130a, and miR-335, which are downregulated in drug-resistant cell lines and promote upregulation of M-CSF (macrophage colony-stimulating factor), a previously described resistance factor for ovarian cancers ( ). 299
Collectively, all these studies show that appropriate control of specific miRNA concentrations in tumors may have beneficial impacts on tumor initiation and promotion. One main obstacle to these therapeutic strategies, as pointed by Purow ( ), probably relates to the 285 correct delivery of the miRNA mimics or antagonists to tumor cells. 
Conclusion
Figure 3
Comparison of miRNAs, siRNAs, and piRNAs miRNAs are processed according to the pathway described in . Figure 2 siRNAs come from exogenous double-stranded RNA (Exo-dsRNA; viral infection) or endogenous double-stranded RNA (Endo-dsRNA; reverse transcription or transposons). Like miRNAs, siRNAs are matured by Dicer associated with TRBP and then incorporated into the RISC complex mainly composed of Ago2. siRNAs play a role in cell defense after a viral infection, in the inhibition of transposon propagation, or in the simple regulation of gene expression. piRNAs are different from miRNAs and siRNAs mainly because of their origin and their maturation; they are derived from single-stranded RNAs and are not processed by Dicer. They are also a few nucleotides longer than miRNAs and siRNAs, are mainly present in germinal cell lines, and contribute to maintaining the genome integrity targeting transposable elements.
Figure 4
Localization of miRNA coding genes located in gene units coding for pre-mRNAs ( ) 31 miRNAs can be located in transcription units not coding for proteins (A) or coding for proteins (B). miRNAs can also be located in either the intron (1) or exon (2).
Figure 5
Maturation of pri-miRNA into pre-miRNA by the Drosha/DGCR8 complex ( ) 43 DGCR8 binds to double-stranded RNA, recognizes the pri-miRNA flanking sequences, and allows the stem-loop cleavage by the ribonuclease Drosha, approximately 11 bp from the junction between the flanking sequences and the stem-loop. This asymmetric cleavage leaves two unpaired nucleotides at the 3 OH end. 
Figure 7
Mechanism of pre-miRNA export from the nucleus to the cytoplasm ( ) 48 The Exp-5/RAN-GTP/pre-miRNA complex binds to nucleoporins in the nucleus and goes through the nuclear pores. The release of pre-miRNAs into the cytoplasm is linked to the hydrolysis of RAN-bound GTP by the RAN-GTPase-activating protein. Exp-5 is then transported back into the nucleus and RAN-GTP is regenerated with RCC1 (Ran guanine nucleotide exchange factor). 
Figure 11
The three different categories of target sites: canonical, marginal, and atypical sites ( ) 97 Canonical sites are composed of complementary sites of 7 or 8 nucleotides at the miRNA 5 end (6 seed region nucleotides position 1 and/or ′ + 8). Marginal sites encompass complementarity sites for only 6 nucleotides in the seed region or 6 nucleotides between positions 3 and 8).
Atypical sites show strand complementarity at the 3 end of miRNA to compensate for weak base-pairing in the 5 region. m8: nucleotide in 
Figure 13
Implication of miRNAs in the apoptosis process ( ) 235 In the intrinsic pathway, the pro-apoptotic protein Puma is the target of miR-221/222 and is regulated by p53, target of the protein SIRT1, itself regulated by miR-34a. Anti-apoptotic protein Bcl-2 is the direct target of miR-15a/16, and Bcl-xL is the indirect target of some members of the miR-17/92 and miR-106b/25 clusters that regulate the pro-apoptotic protein Bim. Several miRNAs repress the apoptosome proteins, such as miR-21 targeting APAF-1 and miR-133 targeting caspase-9. miR-1 is a pro-apoptotic miRNA targeting HSP60 and HSP70, proteins that inhibit apoptosome formation. In the extrinsic pathway, concerning the CD95 receptor and its ligand CD95L (or FAS-L), miR-21 acts as a repressor of this ligand, whereas miR-182 lowers FADD expression. miR-21 also plays a role in caspase-3 regulation.
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